ENDRA Life Sciences to Report Third Quarter 2021 Financial Results on November 15, 2021
November 08 2021 - 8:00AM
Business Wire
ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of
enhanced ultrasound technologies, today announced that the company
will report financial results for the third quarter of 2021 on
Monday, November 15, 2021 after the close of trading on the U.S.
financial markets. Management will host a conference call and
webcast beginning at 4:30 p.m. Eastern time to discuss the results,
provide an update on recent corporate developments and answer
questions.
Participants are encouraged to pre-register for the conference
call using this link. Callers who pre-register will be given a
unique PIN to gain immediate access to the call and bypass the live
operator. Participants may register at any time, including up to
and after the call start time. A webcast of the call may also be
accessed at ENDRA’s Investor Relations page and here. Those without
internet access or unable to pre-register may dial in by calling
(866) 777-2509 (U.S.) or (412) 317-5413 (International).
A replay of the webcast will be available beginning
approximately one hour after the completion of the live conference
call here. A dial-in replay of the call will be available until
November 22, 2021 by calling (877) 344-7529 (U.S.) or (412)
317-0088 (International) and providing the passcode 10161144.
About ENDRA Life Sciences Inc.
ENDRA Life Sciences is the pioneer of Thermo Acoustic Enhanced
UltraSound (TAEUS®), a ground-breaking technology being developed
to visualize tissue like MRI, but at 1/50th the cost and at the
point of patient care. TAEUS® is designed to work in concert with
400,000 cart-based ultrasound systems in use globally today. TAEUS®
is initially focused on the measurement of fat in the liver as a
means to assess and monitor Non-Alcoholic Fatty Liver Disease
(NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver
conditions that affect over one billion people globally, and for
which there are no practical diagnostic tools. Beyond the liver,
ENDRA is exploring several other clinical applications of TAEUS®,
including visualization of tissue temperature during energy-based
surgical procedures. For more information, please visit
www.endrainc.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211108005082/en/
Company Contact: Irina Pestrikova Senior Director,
Finance investors@endrainc.com www.endrainc.com
Investor Relations Contact: Yvonne Briggs LHA Investor
Relations (310) 691-7100 ybriggs@lhai.com
ENDRA Life Sciences (NASDAQ:NDRA)
Historical Stock Chart
From Aug 2024 to Sep 2024
ENDRA Life Sciences (NASDAQ:NDRA)
Historical Stock Chart
From Sep 2023 to Sep 2024